Table 4 Procedure-related complications
From: Long-term outcome after mitral valve replacement using biological versus mechanical valves
Biological MVR N = 265 | Mechanical MVR N = 59 | Odds Ratio 95% CI | Adjusted Odds Ratioa 95% CI | |
|---|---|---|---|---|
Wound infection, % | 9/265 (3.4) | 1/59 (1.7) | 2.04 (0.25–16.41) | 1.01 (0.11–9.77) |
Pericardial tamponade, % | 21/265 (7.9) | 5/59 (8.5) | 0.93 (0.34–2.58) | 0.67 (0.22–2.05) |
AV block grade III, % | 22/265 (8.3) | 5/59 (8.5) | 0.98 (0.35–2.70) | 0.57 (0.18–1.75) |
Pneumonia, % | 27/265 (10.2) | 5/59 (8.5) | 1.23 (0.45–3.33) | 1.02 (0.35–2.97) |
Pneumothorax, % | 2/265 (0.8) | 2/59 (3.4) | 0.22 (0.03–1.57) | 0.22 (0.02–1.98) |
Pleural effusion, % | 12/265 (4.5) | 1/59 (1.7) | 1.59 (0.19–13.44) | 1.62 (0.18–14.45) |
Atrial fibrillation, % | 59/265 (22.3) | 9/59 (15.3) | 1.60 (0.74–3.44) | 1.09 (0.47–2.51) |
MVI ≥ II post OP, % | 6/264 (2.3) | 1/59 (1.7) | 1.35 (0.16–11.42) | 1.86 (0.20–17.31) |
Immediate 72 h procedural mortality, % | 6/265 (2.3) | 0/59 (0) | n.a. | n.a. |